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ABSTRACT
Neuron-specific enolase (NSE) and non-neuronal enolase (NNE) were purified using a small number of meth­
ods performed in the following order: DEAE-cellulose chromatography, diafiltration, preparative isoelectric 
focusing and gel-filtration. Pure isoenzymes were isolated in quantities, which would allow us to produce anti­
sera against each form of the enzyme.
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INTRODUCTION
Enolase (2-phospho-D-glycerate hydrolase, EC 4.2.1.11 ), a 
glycolytic enzyme, catalyzes the interconversion of
2-phosphoglycerate to phosphoenolpyruvate (6). Three dis­
tinct dimer isoenzymes of enolase exsist in mature brain tis­
sue: yy, acx, and ay (2,4,5,17). Homodimer yy predomi­
nantly present in neurons and neuroendocrine cells is also 
referred to as neuron-specific enolase (NSE) (18). 
Homodimer a a  localized in the glial cells is called 
non-neuronal enolase (NNE) (10). Heterodimer ay shown 
to be composed of one NSE subunit and one NNE subunit 
is called intermediate hybrid form (11).
NSE has been of clinical interest as a tumour marker in pa­
tients with neoplasms of the neuroendocrine cells, espe­
cially in those with neuroblastoma and small cell carcinoma 
of the lung (7,19,20).
The aim of the present study was to purify these two 
homodimer forms of enolase from human brain tissue by 
using a small number of steps and to obtain a sufficient 
quantity of the purified isoenzymes that could allow us to 
produce antisera against each form for a further study.
M ATERIAL AND M ETHODS
Human brain tissue obtained at autopsy no more than 12h 
post mortem was minced and homogenized (l:3w/v) in a 
washing/equilibrating buffer (WEB): lOmM Tris.HCl 
(Merck, Germany) containing 5mM MgS04 (Merck, Ger­
many) at pH 7,8. The homogenate was centrifuged at
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l00000xg, 4°C, for 60min and the supernatant was passed 
through a column (50x160) mm of DEAE-cellulose 
(Reanal, Hungary) previously equilibrated with the above 
described buffer. The column was eluted with a linear gra­
dient of KC1 from 0 to 0,6mol in WEB at 4°C. 
Ultradialysis and concentration were performed at 4oC 
against WEB with ultrafiltration apparatus constructed by 
us (1) using SM/14549 20000D membranes (Sartorius, 
Germany).
Preparative isoelectric focusing experiments were per­
formed in Rotophor Bio-Rad camera (BioRad, USA) using 
25% glycerine (Merck, Germany) and 2% amfoline, pH
3-10 (BioRad) at 12W, 9-10mA, 1200-1300V, 4°C for 4 
hours.
Gel-filtration was performed with a column (250x760mm) 
of Sephacryl S-200 (Pharmacia, Sweden) equilibrated with 
50mM Tris.HCl buffer containing 5 mM MgS04, 0,1 mM 
EDTA-Na, pH 7,3. The fractions exhibiting enzyme activ­
ity were pooled and concentrated with 40-80% ammonium 
sulphate.
Analytical electrophoresis was carried out on cellu­
lose-polyacetate membranes (CPM) (Sartorius, Germany) 
using 20mM Tris.HCl pH 7,6 containing lOmM MgS04 
and 0,1% human serum albumin (Sigma, USA) at 2-3 mA, 
20°C for 50min with Sartophor electrophoresis camera 
(Sartorius, Germany). CPMs were developed according to 
the method of zymograms (20). The CPMs to be assayed 
were placed on agar film containing 2% agar; 200mM 
Tris.HCl pH 7,6; 7,3mM D-2-phosphoglyceric acid barium 
salt; 1 mM NADH; 7,6mM ADP; 18,7mM MgS04; 50mM 
KC1; 27,3 lU/ml lactate dehydrogenase, and 15 IU/ml 
pyruvate kinase.
The development was allowed to proceed for 15-20 min at 
37°C. The region producing NADH oxidation was visually 
observed by the loss of fluorescence at 366nm.
The isoelectric focusing experiments in analytical mode
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were carried out with 150mM precois (pH 3-10 or 4-6) 
(Serva, Germany) in Sartophor electrophoresis camera.
elution volume (ml]
Fig. I. Elution profile o f enolase isoenzymes in human 
brain homogenate - DEAE-cellulose chromatography
 collected fractions;  relative protein content;
■—■ enolase activity profile
The precots were stained using non-specific methods for 
proteins (13) and tested for enolase activity (14). Enolase 
activity was spectrophotometrically estimated (VSU 2P, 
Germany) at 366nm, 37°C by coupling the reaction with 
pyruvate kinase and lactate dehydrogenase (Boehringer, 
Germany) (17).
Protein concentration was measured spectrophotometri­
cally with the spectrophotometer of the same type at 280nm 
(15).
RESULTS AND DISCUSSION
The first step in the purification of enolase was by 
DEAE-ion-exchange chromatography. Fig. 1 presents the 
elution profile of the homogenate.
NSE HYBRID NNE
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Fig. 2. CPM - electrophoretic scheme o f enolase 
isoenzymes I - homogenate; 2 - peak 2; 3 - peak 1; 2(?) 
samples with 2,7-3,8 lU/ml enzyme activity were 
applied
Two distinct peaks of enolase activity were detected on the 
chromatogram: peak 1 produced by non-adsorbed enolase 
(fraction 1) which was thought to correspond to the 
aa-form of enolase (NNE) and peak 2 produced by the ad­
sorbed enolase (fraction 2) thought to correspond to ay + yy 
isoforms (hybrid + NSE). In order to prove that fraction 1 
contains exclusively NNE and fraction 2 - NSE + Hybrid
form, these two tractions were separately ultrafiltrated and 
concentrated, then analyzed by CPM-electrophoresis (Fig. 
2) (9). After the isoelectric focusing of fraction 1 in prepara­
tive mode a peak with maximal activity at pH 8,2 was ob­
tained (Fig. 3).
Fig. 3. Preparative isofocusing oj fraction 1
 collected fractions; ■—■ enolase activity profile;
•— »pH gradient
Two peaks with maximal activity at pH 5,4 and 6,4 were 
obtained after isoelectric focusing of fraction 2 (Fig. 4).
Fig. 4. Preparative isofocusing o f  fraction 2
 collected fractions; ■—■ enolase activity profile;
•—•pH  gradient
The peak on Fig. 3 (fractions 14-17) and the peak 1 on Fig. 
4 (fractions 3-5) designated as NNE and NSE, respectively, 
were further purified by gel-filtration (Fig. 5 and Fig. 6). 
The obtained fractions with maximal enzyme activity 
(NNE - fractions 22-33; NSE - fractions 25-35) were col­
lected, precipitated with ammonium sulphate (40-80%) and 
kept at 4°C in excess of ammonium sulphate. Aliquotes 
from each preparation were ultradialysed against WEB 
(membrane 20000D) for analytic isoelectric focusing.
Each of the purified NNE or NSE preparations produces a 
single band with enolase activity after analytical 
isofocusing. The data about the specific activity of these 
two homodimeric isoenzymes are comparable with these 
reported by other authors (4,5,11,17).
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Fig. 5. Gel-filtration on Sephacryl S-200 o f the peak
from Fig. 3  collected fractions;  relative
protein content; ■—■ enolase activity profde
The results from the present study reveal that good purifica­
tion of two homodimeric isoforms of human brain enolase 
could be achieved using a small number of purification pro­
cedures such as DEAE-chromatography, diafiltralion, 
isoelectric focusing, and gel-filtration whereas the proce­
dures described by others (3,4,8,12,17) include 7-11 purifi­
cation steps.
Fig. 6. Gel-filtration on Sephacryl S-200 o f the collected
fractions o f  peak I from Fig. 4  collected fractions;
 relative protein content; ■—■ enolase activity
profile
Using this scheme of purification we have obtained suffi­
cient quantities of the purified isoenzymes (NSE and NNE) 
allowing us to produce specific antisera.
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